DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo


43.60 0.06 (0.14%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLVS $43.60 0.14%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.28
Previous Close $43.54
Daily Range $42.80 - $43.79
52-Week Range $35.33 - $93.33
Market Cap $1.5B
P/E Ratio -12.26
Dividend (Yield) $0.00 (0.0%)
Volume 495,246
Average Daily Volume 590,448
Current FY EPS -$4.20




Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring developing and commercializing innovative anti-cancer agents in the United States Europe and additional international markets. Website:

News & Commentary

Better Buy: Clovis Oncology vs. Sunesis Pharmaceuticals

Clovis Oncology and Sunesis Pharmaceuticals are facing pivotal catalysts for their experimental cancer drugs. Which company offers the better risk-to-reward ratio?

Top Swing Trade Ideas for Monday, August 11: Coach, Clovis Oncology, More

Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q2 2014 Results - Earnings Call Transcript

Biotech Enters Reporting Season With Large Caps Central To Sector Performance

3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology

Puma Biotechnology (PBYI), Clovis Oncology (CLVS), and Hyperion Therapeutics (HPTX) all stumbled by more than 10% in June.

Interesting CLVS Put And Call Options For August 16th

Clovis Oncology Initiates Study on CO-1686 - Analyst Blog

Sector Update: Healthcare

Sector Update: Healthcare Shares Mixed Pre-Market; AbbVie Lifts on Fiscal 2014 Guidance

Stock Market Price Action Should Be Higher Early This Week

See More CLVS News...